These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36977656)

  • 21. Physical functional capacity in idiopathic pulmonary fibrosis: performance characteristics of the continuous-scale physical function performance test.
    Olson AL; Swigris JJ; Belkin A; Hannen L; Yagihashi K; Schenkman M; Brown KK
    Expert Rev Respir Med; 2015 Jun; 9(3):361-7. PubMed ID: 25843290
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validation of the Modified Pulmonary Functional Status and Dyspnea Questionnaire and the Medical Research Council scale for use in Brazilian patients with chronic obstructive pulmonary disease.
    Kovelis D; Segretti NO; Probst VS; Lareau SC; Brunetto AF; Pitta F
    J Bras Pneumol; 2008 Dec; 34(12):1008-18. PubMed ID: 19180335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patient confidence and quality of life in idiopathic pulmonary fibrosis and sarcoidosis.
    Kotecha J; Atkins C; Wilson A
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Dec; 33(4):341-348. PubMed ID: 28079846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical validation of the Swedish version of Dyspnoea-12 instrument in outpatients with cardiorespiratory disease.
    Sundh J; Bornefalk H; Sköld CM; Janson C; Blomberg A; Sandberg J; Bornefalk-Hermansson A; Igelström H; Ekström M
    BMJ Open Respir Res; 2019; 6(1):e000418. PubMed ID: 31673362
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Marked deterioration in the quality of life of patients with idiopathic pulmonary fibrosis during the last two years of life.
    Rajala K; Lehto JT; Sutinen E; Kautiainen H; Myllärniemi M; Saarto T
    BMC Pulm Med; 2018 Nov; 18(1):172. PubMed ID: 30458739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and Initial Validation Analyses of the Living with Idiopathic Pulmonary Fibrosis Questionnaire.
    Swigris JJ; Andrae DA; Churney T; Johnson N; Scholand MB; White ES; Matsui A; Raimundo K; Evans CJ
    Am J Respir Crit Care Med; 2020 Dec; 202(12):1689-1697. PubMed ID: 32634038
    [No Abstract]   [Full Text] [Related]  

  • 27. Functional predictors of exertional dyspnea, 6-min walking distance and HRCT fibrosis score in idiopathic pulmonary fibrosis.
    Mura M; Ferretti A; Ferro O; Zompatori M; Cavalli A; Schiavina M; Fabbri M
    Respiration; 2006; 73(4):495-502. PubMed ID: 16484770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Validation of the risk stratification score in idiopathic pulmonary fibrosis: study protocol of a prospective, multi-centre, observational, 3-year clinical trial.
    Manzetti GM; Hosein K; Cecchini MJ; Kwan K; Abdelrazek M; Zompatori M; Rogliani P; Mura M
    BMC Pulm Med; 2021 Dec; 21(1):396. PubMed ID: 34863146
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD8+ T lymphocytes in lung tissue from patients with idiopathic pulmonary fibrosis.
    Daniil Z; Kitsanta P; Kapotsis G; Mathioudaki M; Kollintza A; Karatza M; Milic-Emili J; Roussos C; Papiris SA
    Respir Res; 2005 Jul; 6(1):81. PubMed ID: 16042790
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum levels of oxidative stress as a marker of disease severity in idiopathic pulmonary fibrosis.
    Daniil ZD; Papageorgiou E; Koutsokera A; Kostikas K; Kiropoulos T; Papaioannou AI; Gourgoulianis KI
    Pulm Pharmacol Ther; 2008; 21(1):26-31. PubMed ID: 17161968
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of lung deformation in patients with idiopathic pulmonary fibrosis with elastic registration technique on pulmonary three-dimensional ultrashort echo time MRI.
    Yang X; Yu P; Sun H; Deng M; Liu A; Li C; Meng W; Xu W; Xie B; Geng J; Ren Y; Zhang R; Liu M; Dai H
    Insights Imaging; 2024 Jan; 15(1):17. PubMed ID: 38253739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differences in response to pulmonary rehabilitation in idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease.
    Kozu R; Senjyu H; Jenkins SC; Mukae H; Sakamoto N; Kohno S
    Respiration; 2011; 81(3):196-205. PubMed ID: 20516666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dyspnea Associates With a Widely Impaired Quality of Life in Idiopathic Pulmonary Fibrosis Patients: A Longitudinal Study Using 15D.
    Rautajoki T; Lehto JT; Sutinen E; Bergman P; Sintonen H; Rajala K; Mäkelä K; Hollmen M; Saarto T; Myllärniemi M
    J Palliat Med; 2023 Oct; 26(10):1357-1364. PubMed ID: 37366772
    [No Abstract]   [Full Text] [Related]  

  • 34. Six-minute-walk test in idiopathic pulmonary fibrosis: test validation and minimal clinically important difference.
    du Bois RM; Weycker D; Albera C; Bradford WZ; Costabel U; Kartashov A; Lancaster L; Noble PW; Sahn SA; Szwarcberg J; Thomeer M; Valeyre D; King TE
    Am J Respir Crit Care Med; 2011 May; 183(9):1231-7. PubMed ID: 21131468
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reliability and validity of Chinese version of a tool to assess the quality of life in idiopathic pulmonary fibrosis in patients with interstitial lung disease.
    Pan RL; Swigris JJ; Zhao YW; Guo AM; Wu Q; Li SJ
    Int J Nurs Sci; 2019 Jan; 6(1):38-42. PubMed ID: 31406867
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Buccal Hydromorphone Syrup for Managing Dyspnea in Idiopathic Pulmonary Fibrosis.
    Fong S; Richman-Eisenstat J; Kalluri M
    Am J Hosp Palliat Care; 2021 Aug; 38(8):1046-1052. PubMed ID: 33138638
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dyspnea scales as a measure of health-related quality of life in patients with idiopathic pulmonary fibrosis.
    Baddini Martinez JA; Martinez TY; Lovetro Galhardo FP; de Castro Pereira CA
    Med Sci Monit; 2002 Jun; 8(6):CR405-10. PubMed ID: 12070430
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Item selection, reliability and validity of the Shortness of Breath with Daily Activities (SOBDA) questionnaire: a new outcome measure for evaluating dyspnea in chronic obstructive pulmonary disease.
    Wilcox TK; Chen WH; Howard KA; Wiklund I; Brooks J; Watkins ML; Cates CE; Tabberer MM; Crim C
    Health Qual Life Outcomes; 2013 Nov; 11():196. PubMed ID: 24229361
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fatigue in sarcoidosis and idiopathic pulmonary fibrosis: differences in character and severity between diseases.
    Atkins CP; Gilbert D; Brockwell C; Robinson S; Wilson AM
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Aug; 33(2):130-8. PubMed ID: 27537715
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validation of the Clinical COPD Questionnaire as a psychophysical outcome measure in adult laryngotracheal stenosis.
    Nouraei SA; Randhawa PS; Koury EF; Abdelrahim A; Butler CR; Venkataraman A; Howard DJ; Sandhu GS
    Clin Otolaryngol; 2009 Aug; 34(4):343-8. PubMed ID: 19673982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.